Skip To The Main Content
background

Press Releases

  • PDA Confirms U.S. FDA’s Douglas Throckmorton as an Opening Plenary Speaker for Virtual 2020 PDA/FDA Joint Regulatory Conference

    8/4/2020 12:53:00 PM
    Bethesda, Md. – The Parenteral Drug Association (PDA) today announced that it has confirmed Douglas Throckmorton, MD, Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research (CDER), U.S. FDA, as an opening plenary speaker of the 2020 PDA/FDA Joint Regulatory Conference, which will be held virtually Sept. 14 – 16.
  • BSR/PDA Standard 02-201x Cryopreservation Standard Available for Public Comment

    7/23/2020 8:56:00 PM
    Bethesda, Md. – The Parenteral Drug Association (PDA) today announced the availability of BSR/PDA Standard 02-201x, Cryopreservation of Cells for Use in Cell Therapies and Regenerative Medicine Manufacturing for public comment. To receive a copy of this draft standard, email PDA at [email protected] The public comments period concludes September 7, 2020 EDT. There is no charge for the draft standard.
  • PDA Launches New Website for the PDA Foundation, a 501(c)(3) Organization Site includes a donation section for companies to underwrite certain PDA activities

    6/1/2020 2:11:00 PM
    Bethesda, Md. – The Parenteral Drug Association (PDA) today announced the availability of a new website for the PDA Foundation, a 501(c)(3) nonprofit founded in 1997 to help support PDA and other industry activities. This new website makes it easier for industry stakeholders to donate money for various activities, as it includes an online processing system.
  • PDA Forms Coronavirus Pandemic Response Task Force, New Advanced Therapy Advisory Board

    4/23/2020 2:51:00 PM
    Bethesda, Md. – The Parenteral Drug Association, Inc. (PDA) today announced two new volunteer opportunities and changes to its Board of Directors/Executive Committee following its spring Board of Directors meeting.
  • PDA Announces Availability of ANSI/PDA Standard 001-2020 on Purchasing Controls

    4/17/2020 6:10:00 PM
    Bethesda, Md. – The Parenteral Drug Association (PDA) today announced the availability of ANSI/PDA Standard 001-2020, Enhanced Purchasing Controls to Support the Bio-Pharmaceutical, Pharmaceutical, Medical Devices, and Combination Products Industries, which was approved by the ANSI Board of Standards Review on March 13, 2020.
  • Parenteral Drug Association Announces its 2020 – 2026 Strategic Plan

    4/7/2020 2:42:00 PM
    Bethesda, Md. – The Parenteral Drug Association, Inc. (PDA) today announced the availability of its 2020 – 2026 Strategic Plan, which was developed to assist PDA in achieving its vision to be the premier global leader in advancing bio/pharmaceutical manufacturing, science, technology, and regulation to enable members to better serve patients. The plan was developed by PDA’s Strategic Planning Committee at the direction of the PDA Board of Directors.
  • Parenteral Drug Association Announces Measures to Support Pharma/Biopharma Industries during Covid-19 Pandemic

    3/27/2020 6:57:00 PM
    Bethesda, Md. – The Parenteral Drug Association (PDA) announced that it is suspending membership expirations retroactively to March 1 and continuing until the end of June. All members will continue to enjoy the benefits of membership, even if you are unable to pay due to the impact of the corona virus pandemic.
  • PDA Names Former Eli Lilly Exec. Glenn E. Wright Vice President of Scientific and Regulatory Affairs Dr. Tina Morris is leaving PDA to become Executive Director at AAPS

    3/10/2020 1:05:00 PM
    Bethesda, Md. – The Parenteral Drug Association (PDA) today announced the appointment of former Eli Lilly and Co. - Executive Glenn E. Wright as Vice President of Scientific and Regulatory Affairs, effective March 23. Mr. Wright most recently worked as Senior Director of Quality Operations at Exelead, a contract manufacturer. Mr. Wright also has worked for Amgen and Pfizer.
  • PDA Europe Parenteral Packaging to Address EU MDR 117 and Closed Systems

    2/12/2020 3:20:00 PM
    Berlin – Parenteral Drug Association Europe (PDA EU) is hosting its 10th Parenteral Packaging Conference in Basel, Switzerland, 25-26 February. The conference features presentations and discussions by industry leaders and technical experts from pharma and supplier companies. This year’s event includes expert discussions on the EU’s Medical Device Regulation 117 and on closed system transfer devices.
  • PDA and AAMI Announce Plans to Explore Collaborations

    2/5/2020 2:04:00 PM
    Bethesda, Md. – The Parenteral Drug Association (PDA) and the Association for the Advancement of Medical Instrumentation (AAMI) today announced their agreement to explore collaborations to further the missions of both organizations and enhance value to their members, stakeholders, and their respective communities at large. The two heads of each organization met at PDA’s headquarters on Jan. 29 to sign a collaboration agreement.
  • PDA Announces 2020 United States Conference Schedule

    1/28/2020 3:26:00 PM
    Bethesda, Md. – The Parenteral Drug Association (PDA) today announced its schedule of U.S. conferences for the year. The busy schedule includes PDA’s signature events and new “hot topic” workshops.
  • PDA Europe Releases 2020 Conference Schedule

    12/17/2019 6:44:00 PM
    Berlin – The Parenteral Drug Association (PDA) Europe today announced its 2020 events calendar, which includes nine conferences throughout the EU. These events are developed by all-volunteer subject-matter experts who work with PDA staff to help educate pharmaceutical professionals on important topics related to biopharmaceuticals, manufacturing science, and regulatory affairs.
  • PDA and IPEC Federation Publish Technical Report No. 54-6 Formalized Risk Assessment for Excipients

    12/17/2019 6:44:00 PM
    Bethesda, Md., / Brussels, Belgium – The Parenteral Drug Association (PDA) and the International Pharmaceutical Excipients Council Federation (IPEC) as an outcome of its collaboration established in March 2018, today announce the joint publication of a Technical Report for Formalized Risk Assessment for Excipients.
  • PDA Announces Election Results for 2020 Board of Directors; Jette Christensen Assumes Role as Chair, 2020-2021

    12/9/2019 3:42:00 PM
    Bethesda, Md. – The Parenteral Drug Association (PDA) today announced the results of its Board of Directors Election for the term beginning January 1, 2020. Each year, PDA’s global membership votes to select new directors for the nonprofit Association’s all volunteer Board of Directors, and the Board appoints one Director. In odd years, the membership elects new volunteer officers, who serve two-year terms (except for the chair elect, who serves for six years as chair-elect, chair, and, finally, as immediate-past-chair).
  • PDA GMP for APIs Education Webinar Now an "ICH Recognised Training Programme"

    12/4/2019 1:42:00 PM
    Bethesda, Md. – The Parenteral Drug Association (PDA) is proud to announce that its “ICH Q7 GMP for APIs” online training module is now endorsed by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use as an “ICH Recognised Training Programme.”
  • U.S. FDA’s CDER Director Janet Woodcock and Johns Hopkins Researcher Thomas Stanton to Headline 2019 PDA Quality Week

    11/5/2019 2:37:00 PM
    Bethesda, Md., – The Parenteral Drug Association (PDA) today announced the participation of U.S. FDA Center for Drug Evaluation and Research Director (CDER), Janet Woodcock, MD, and Johns Hopkins University researcher and author, Thomas Stanton, MA/JD, as keynote speakers for the 2019 PDA Risk Management in the Regulatory Landscape Conference, at the Capital Hilton, Washington, DC, Dec. 9–10. The conference is the first of three during PDA’s first “Quality Week.”
  • PDA Announces First Drug Delivery Innovation Award Winners at 2019 Universe of Pre-Filled Syringes and Injection Devices Conference

    10/29/2019 6:44:00 PM
    Bethesda, Md. – The Parenteral Drug Association (PDA) announced FujiFilm Kyowa Kirin Biologics, Co., Ltd. has won PDA’s new Drug Delivery Innovation Award and Congruence Medical Solutions and Santen Pharmaceuticals have won PDA’s Partnership in Drug Delivery Innovation Award. The Drug Delivery Awards were introduced in 2019 to recognize technical innovation advancing the field of bio/pharmaceutical manufacturing.
  • ISPE and PDA Publish Guide to Improving Quality Culture in Pharmaceutical Industry

    10/8/2019 12:30:00 PM
    Bethesda, Md. – The Parenteral Drug Association (PDA) and the International Society for Pharmaceutical Engineering (ISPE) today announce the joint publication of a guide for Root Cause Analysis (RCA) to help the pharmaceutical industry improve quality culture by providing recommendations for tools, techniques, and processes.
  • BSR/PDA Standard 01-201x on Purchasing Controls Available for Public Comment

    9/24/2019 4:11:00 PM
    Bethesda, Md. – The Parenteral Drug Association (PDA) today announced the availability of BSR/PDA Standard 01-201x, Enhancing Purchasing Controls to Support the Biopharmaceutical, Pharmaceutical, Medical Devices and Combination Products Industry for public comment.
  • PDA Announces Keynote Speakers for 2019 PDA/FDA Joint Regulatory Conference

    8/20/2019 3:28:00 PM
    Bethesda, Md. – PDA is excited to announce the keynote speakers for the upcoming PDA/FDA Joint Regulatory Conference September 16-18 in Washington, D.C. These and other expert speakers will share their insight on how to improve the continued supply of high-quality drugs, biologics, and novel combination products to patients.